Moderna sues Pfizer for mRNA Patent Infringement: when optics and profits reveal real issues in modern IP law usage
IPilogue
NOVEMBER 3, 2022
Moderna and Pfizer battle’s over the inventive process of their respective mRNA COVID-19 vaccines revisit the negative associations of profit, monopolies, and optics in patent litigation. Moderna claimed that they had registered foundational mRNA patents between 2010 and 2016. This exposes some concerns about our patent laws.
Let's personalize your content